Quick Summary
- Texas Instruments exceeded Q1 2026 projections with earnings per share of $1.68 compared to the anticipated $1.36
- Total revenue reached $4.83 billion, surpassing the projected $4.52 billion
- The Industrial division expanded over 20% sequentially; Data Center operations climbed more than 25%
- Barclays elevated TXN to Equalweight, increasing its target from $175 to $250
- Several Wall Street firms increased their price objectives, with KeyBanc reaching $325 and Rosenblatt hitting $330
Texas Instruments delivered robust first-quarter 2026 performance, surpassing Wall Street projections across key metrics. Earnings per share reached $1.68, significantly exceeding the consensus estimate of $1.36. Total revenue landed at $4.83 billion against analyst forecasts of $4.52 billion.
Shares rallied approximately 16% following the announcement, climbing from roughly $233 to approximately $274.
Texas Instruments Incorporated, TXN
The outstanding performance stemmed from robust momentum across two critical business segments: Industrial and Data Center. The Industrial division posted sequential growth exceeding 20% during the March quarter. Meanwhile, Data Center operations expanded by more than 25% during the identical timeframe.
Second-quarter outlook came in moderately ahead of typical seasonal patterns, suggesting sustained strength in both divisions. Automotive sector demand continued to show volatility, per UBS analysis.
Wall Street Reactions and Target Adjustments
Barclays delivered the most significant rating change, elevating TXN from Underweight to Equalweight while boosting its price objective from $175 to $250. The investment bank attributed the shift to enhanced fundamentals in Industrial and Data Center operations.
Barclays projects Data Center revenue will surge over 90% throughout full-year 2026. The firm also anticipates Industrial will outperform seasonal expectations again in the June quarter.
The bank now forecasts $10 per share in free cash flow for TXN during calendar 2027. This projection stands above the current Street consensus of approximately $8.55.
UBS maintained its Buy recommendation while elevating its target from $260 to $295. The firm noted results aligned with heightened market expectations, while forward guidance provided a modest upside surprise.
Cantor Fitzgerald increased its objective from $250 to $280 while maintaining a Neutral stance. The firm applied an expanded 28x valuation multiple versus the prior 25x, reflecting strengthening trends across analog semiconductor markets.
Additional Analyst Perspectives
KeyBanc established the most optimistic target, raising it to $325. BofA Securities upgraded TXN to Buy with a $320 price objective, highlighting momentum in aerospace and defense applications within the industrial category.
Rosenblatt elevated its target to $330. Baird adjusted upward to $300. Wolfe Research, which observed Q1 revenue increased 9% sequentially, established a $315 target.
TXN currently commands approximately 26 times free cash flow, elevated compared to its historical mid-teens valuation range. The price-to-earnings ratio stands at 43.15.
Barclays cautioned that the company still faces execution challenges regarding Street estimates for the latter half of the year. Cantor Fitzgerald also highlighted concerns surrounding memory supply constraints and geopolitical uncertainties as factors warranting selectivity across the broader semiconductor sector.
Shares were changing hands near $274, approaching the 52-week high of $238.80 established prior to the post-earnings surge.
